Cargando…
Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study)
Germline TP53 pathogenic variants are rare but associated with a high risk of cancer; they are often identified in the context of clinically diagnosed Li–Fraumeni syndrome predisposing to a range of young onset cancers including sarcomas and breast cancer. The study aim was to conduct a detailed mor...
Autores principales: | Packwood, Kate, Martland, Guy, Sommerlad, Matthew, Shaw, Emily, Moutasim, Karwan, Thomas, Gareth, Bateman, Adrian C, Jones, Louise, Haywood, Linda, Evans, D Gareth, Birch, Jillian M, Alsalmi, Ohud A, Henderson, Alex, Poplawski, Nicola, Eccles, Diana M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648388/ https://www.ncbi.nlm.nih.gov/pubmed/31041842 http://dx.doi.org/10.1002/cjp2.133 |
Ejemplares similares
-
Germline TP53 Testing in Breast Cancers: Why, When and How?
por: Evans, D. Gareth, et al.
Publicado: (2020) -
Germline TP53 mutations in Finnish breast cancer patients
por: Rapakko, K, et al.
Publicado: (2000) -
Clinical implications of germline mutations in breast cancer: TP53
por: Schon, Katherine, et al.
Publicado: (2017) -
Germline TP53 mutational spectrum in French Canadians with breast cancer
por: Arcand, Suzanna L, et al.
Publicado: (2015) -
Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)